
CRH Medical Corporation CRHM
Country |
|
IPO year |
2015 |
Industry |
Medical instruments |
Stock Exchange |
NYSE AMERICAN |
Shares |
71.5 M |
Market Cap[1] |
$ 282 M |
EBITDA (LTM) |
$ -6.25 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 62.26 | -0.46 % | $ 12.4 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Glaukos Corporation
GKOS
|
$ 114.49 | -4.77 % | $ 6.55 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 67.71 | -0.1 % | $ 40.4 B | NYSE | ||
|
ICU Medical
ICUI
|
$ 136.02 | 2.03 % | $ 3.35 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 115.14 | -1.22 % | $ 3.68 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 437.57 | -0.12 % | $ 156 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.2 | 2.32 % | $ 194 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
LeMaitre Vascular
LMAT
|
$ 98.83 | 1.1 % | $ 2.24 B | Nasdaq Global Market,SPB | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Masimo Corporation
MASI
|
$ 178.65 | -0.09 % | $ 9.52 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.81 | 5.56 % | $ 82.9 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Milestone Scientific
MLSS
|
$ 0.38 | -1.42 % | $ 31.2 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
electroCore
ECOR
|
$ 8.74 | 31.03 % | $ 74.1 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 23.72 | 1.22 % | $ 3.98 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 67.3 | 2.76 % | $ 3.18 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
STERIS plc
STE
|
$ 216.49 | -0.04 % | $ 21.3 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 33.3 | 2.56 % | $ 1.65 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.48 | -1.86 % | $ 196 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 132.23 | -0.39 % | $ 5.9 B | NYSE,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 64.43 | 0.41 % | $ 3.81 B | Nasdaq Global Select Market,SPB | ||
|
Utah Medical Products
UTMD
|
$ 64.98 | 0.73 % | $ 211 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 318.94 | 0.8 % | $ 23.1 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.03 | -1.81 % | $ 2 B | Nasdaq Global Select Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 25.97 | 0.31 % | $ 1.75 B | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.68 | -4.19 % | $ 20.4 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 65.15 | 2.57 % | $ 214 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 23.72 | -0.96 % | $ 1.13 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.97 | 2.34 % | $ 179 M | NYSE American | ||
|
Baxter International
BAX
|
$ 19.4 | 1.15 % | $ 9.95 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 208.54 | 0.24 % | $ 30.5 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 28.93 | 2.26 % | $ 1.38 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 5.65 | 0.98 % | $ 251 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 11.86 | -0.5 % | $ 485 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 148.94 | 0.89 % | $ 42.8 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.55 | 2.16 % | $ 37.7 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.86 | 6.93 % | $ 284 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 115.24 | 0.16 % | $ 6.48 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.